Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1986 Apr;76(4):392–396. doi: 10.2105/ajph.76.4.392

Willingness to pay and accept risks to cure chronic disease.

M S Thompson
PMCID: PMC1646507  PMID: 3082226

Abstract

Measurements of disease burden focus most often on economic outputs--neglecting effects on quality of life. More comprehensive quantification is based on what people would pay or risk to avoid illness. Many, however, find it difficult to respond thoughtfully to hypothetical questions about what they would pay or risk. With response rates frequently under 50 per cent, the practicality of these methods has been of concern. In this study, specially trained interviewers asked 247 subjects with rheumatoid arthritis how much of their income they would pay and how large a mortal risk they would accept to achieve a hypothetical cure. Ninety-eight per cent of the subjects estimated their maximum acceptable risk (MAR) at an average 27 per cent chance of immediate death. Eighty-four per cent gave plausible responses to the willingness-to-pay (WTP) questions, with a mean WTP of 22 per cent of household income. The aspect of disease most strongly associated with WTP was impairment in activities of daily living; measured pain was most associated with MAR. The response rates achieved indicate the overall feasibility of these methods; the associations of WTP and MAR with other variables suggest systematic consideration of personal circumstances.

Full text

PDF
392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook R. H., Ware J. E., Jr, Davies-Avery A., Stewart A. L., Donald C. A., Rogers W. H., Williams K. N., Johnston S. A. Overview of adult health measures fielded in Rand's health insurance study. Med Care. 1979 Jul;17(7 Suppl):iii-x, 1-131. [PubMed] [Google Scholar]
  2. Cooper B. S., Rice D. P. The economic cost of illness revisited. Soc Secur Bull. 1976 Feb;39(2):21–36. [PubMed] [Google Scholar]
  3. Eberl D. R., Fasching V., Rahlfs V., Schleyer I., Wolf R. Repeatability and objectivity of various measurements in rheumatoid arthritis. A comparative study. Arthritis Rheum. 1976 Nov-Dec;19(6):1278–1286. doi: 10.1002/art.1780190608. [DOI] [PubMed] [Google Scholar]
  4. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  5. Goddeeris J. H. Theoretical considerations on the cost of illness. J Health Econ. 1983 Aug;2(2):149–159. doi: 10.1016/0167-6296(83)90004-8. [DOI] [PubMed] [Google Scholar]
  6. Hartunian N. S., Smart C. N., Thompson M. S. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. Am J Public Health. 1980 Dec;70(12):1249–1260. doi: 10.2105/ajph.70.12.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hodgson T. A., Meiners M. R. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429–462. [PubMed] [Google Scholar]
  8. Kaplan R. M., Bush J. W., Berry C. C. Health status: types of validity and the index of well-being. Health Serv Res. 1976 Winter;11(4):478–507. [PMC free article] [PubMed] [Google Scholar]
  9. Landefeld J. S., Seskin E. P. The economic value of life: linking theory to practice. Am J Public Health. 1982 Jun;72(6):555–566. doi: 10.2105/ajph.72.6.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MALZBERG B. Mental illness and the economic value of a man. Ment Hyg. 1950 Oct;34(4):582–591. [PubMed] [Google Scholar]
  11. McNeil B. J., Pauker S. G., Sox H. C., Jr, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med. 1982 May 27;306(21):1259–1262. doi: 10.1056/NEJM198205273062103. [DOI] [PubMed] [Google Scholar]
  12. McNeil B. J., Weichselbaum R., Pauker S. G. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978 Dec 21;299(25):1397–1401. doi: 10.1056/NEJM197812212992506. [DOI] [PubMed] [Google Scholar]
  13. McNeil B. J., Weichselbaum R., Pauker S. G. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981 Oct 22;305(17):982–987. doi: 10.1056/NEJM198110223051704. [DOI] [PubMed] [Google Scholar]
  14. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975 Sep;1(3):277–299. doi: 10.1016/0304-3959(75)90044-5. [DOI] [PubMed] [Google Scholar]
  15. Muller A., Reutzel T. J. Willingness to pay for reduction in fatality risk: an exploratory survey. Am J Public Health. 1984 Aug;74(8):808–812. doi: 10.2105/ajph.74.8.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Patrick D. L., Bush J. W., Chen M. M. Methods for measuring levels of well-being for a health status index. Health Serv Res. 1973 Fall;8(3):228–245. [PMC free article] [PubMed] [Google Scholar]
  17. Pauker S. P., Pauker S. G. The amniocentesis decision: an explicit guide for parents. Birth Defects Orig Artic Ser. 1979;15(5C):289–324. [PubMed] [Google Scholar]
  18. Rice D. P., Cooper B. S. The economic value of human life. Am J Public Health Nations Health. 1967 Nov;57(11):1954–1966. doi: 10.2105/ajph.57.11.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rice D. P., Hodgson T. A. The value of human life revisited. Am J Public Health. 1982 Jun;72(6):536–538. doi: 10.2105/ajph.72.6.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sackett D. L., Torrance G. W. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31(11):697–704. doi: 10.1016/0021-9681(78)90072-3. [DOI] [PubMed] [Google Scholar]
  21. Thompson M. S., Read J. L., Liang M. Feasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making. 1984;4(2):195–215. doi: 10.1177/0272989X8400400207. [DOI] [PubMed] [Google Scholar]
  22. Tversky A., Kahneman D. The framing of decisions and the psychology of choice. Science. 1981 Jan 30;211(4481):453–458. doi: 10.1126/science.7455683. [DOI] [PubMed] [Google Scholar]
  23. Weinstein M. C., Stason W. B. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977 Mar 31;296(13):716–721. doi: 10.1056/NEJM197703312961304. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES